Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on UV 9. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110642790B details a novel Rosuvastatin Calcium route using Evans auxiliaries. Achieve high purity solid intermediates and cost reduction in API manufacturing.
Patent CN109574938B reveals a novel synthesis route for Rosuvastatin Sodium featuring mild conditions, high atom economy, and superior stereoselectivity for industrial scale-up.
Advanced stereoselective preparation of Sofosbuvir intermediates via patent CN105153257B. Reduces production costs and enhances supply chain reliability for global pharmaceutical manufacturers.
Solve impurity F challenges in fluvoxamine maleate production. Our one-pot process achieves 89.2% yield with no organic solvent. Contact for GMP manufacturing.